Search Results

There are 204410 results for: content related to: Nilotinib, imatinib, and telomere homeostasis disruption in chronic myeloid leukemia

  1. You have free access to this content
    Expanding Nilotinib Access in Clinical Trials (ENACT)

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 118–126, Franck E. Nicolini, Anna Turkina, Zhi-Xiang Shen, Neil Gallagher, Saengsuree Jootar, Bayard L. Powell, Carmino De Souza, Ming Zheng, Tomasz Szczudlo and Philipp le Coutre

    Article first published online : 5 JUL 2011, DOI: 10.1002/cncr.26249

  2. You have free access to this content
    Nilotinib versus imatinib

    Cancer

    Volume 118, Issue 20, 15 October 2012, Pages: 5181–5182, Rumiana Bakalova, Zhivko Zhelev and Lubomir Spasov

    Article first published online : 25 APR 2012, DOI: 10.1002/cncr.27479

  3. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Article first published online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  4. Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolam

    The Journal of Clinical Pharmacology

    Hefei Zhang, Jennifer Sheng, Jin H. Ko, Cheng Zheng, Wei Zhou, Petra Priess, Wen Lin and Steven Novick

    Article first published online : 27 FEB 2015, DOI: 10.1002/jcph.434

  5. Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 1, January 2011, Pages: 75–83, Dr Chiaki Tanaka, Dr Ophelia Q. P. Yin, Dr Tom Smith, Dr Venkat Sethuraman, Ms Karen Grouss, Dr Lawrence Galitz, Dr Robert Harrell and Dr Horst Schran

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270010367428

  6. Effects of Yogurt and Applesauce on the Oral Bioavailability of Nilotinib in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 11, November 2011, Pages: 1580–1586, Dr Ophelia Q. P. Yin, Dr Marc Rudoltz, Dr Ivana Galetic, Dr Jeiry Filian, Dr Arun Krishna, Dr Wei Zhou, Dr Joseph Custodio, Dr Georg Golor and Dr Horst Schran

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010384116

  7. Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib

    The Journal of Clinical Pharmacology

    Volume 50, Issue 8, August 2010, Pages: 960–967, Dr Ophelia Q. P. Yin, Dr Neil Gallagher, Dr Deirdre Fischer, Dr Eren Demirhan, Dr Wei Zhou, Dr Georg Golor and Dr Horst Schran

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009346061

  8. Clinical Pharmacokinetics of the BCR–ABL Tyrosine Kinase Inhibitor Nilotinib

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 2, February 2010, Pages: 197–203, C Tanaka, O Q P Yin, V Sethuraman, T Smith, X Wang, K Grouss, H Kantarjian, F Giles, O G Ottmann, L Galitz and H Schran

    Article first published online : 18 NOV 2009, DOI: 10.1038/clpt.2009.208

  9. You have free access to this content
    Evaluation of residual CD34+Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy

    Cancer

    Volume 118, Issue 21, 1 November 2012, Pages: 5265–5269, Marzia Defina, Micaela Ippoliti, Alessandro Gozzetti, Elisabetta Abruzzese, Fausto Castagnetti, Rosaria Crupi, Mario Tiribelli, Massimo Breccia, Marzia Salvucci, Lara Aprile, Claudia Baratè, Antonella Gozzini, Gianantonio Rosti, Francesco Lauria and Monica Bocchia

    Article first published online : 19 APR 2012, DOI: 10.1002/cncr.27506

  10. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 10, October 2014, Pages: 788–797, Gamal E Shiha, Nashwa M Abu-Elsaad, Khaled R Zalata and Tarek M Ibrahim

    Article first published online : 30 OCT 2014, DOI: 10.1111/1440-1681.12286

  11. You have free access to this content
    Practical management of patients with chronic myeloid leukemia

    Cancer

    Volume 117, Issue 19, 1 October 2011, Pages: 4343–4354, Francisco Cervantes and Michael Mauro

    Article first published online : 16 MAR 2011, DOI: 10.1002/cncr.26062

  12. Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 50, Issue 2, February 2010, Pages: 188–194, Dr Ophelia Q. P. Yin, Dr Neil Gallagher, Dr Ai Li, Dr Wei Zhou, Dr Robert Harrell and Dr Horst Schran

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009336137

  13. You have free access to this content
    Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia

    European Journal of Clinical Investigation

    Volume 42, Issue 9, September 2012, Pages: 1016–1026, Francis Giles, François-Xavier Mahon, Bjorn Gjertsen, Ronan Swords, Boris Labar, Anna Turkina and Gianantonio Rosti

    Article first published online : 1 MAY 2012, DOI: 10.1111/j.1365-2362.2012.02675.x

  14. Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

    Cancer

    Avichai Shimoni, Yulia Volchek, Maya Koren-Michowitz, Nira Varda-Bloom, Raz Somech, Noga Shem-Tov, Ronit Yerushalmi and Arnon Nagler

    Article first published online : 11 NOV 2014, DOI: 10.1002/cncr.29141

  15. You have full text access to this Open Access content
    Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 5b, October 2008, Pages: 2107–2118, J. Chen, A. Schmitt, B. Chen, M. Rojewski, V. RuBeler, F. Fei, Y. Yu, X. Yu, M. Ringhoffer, S. von Harsdorf, J. Greiner, M. Gbtzz, P. Guillaume, H. Dbhner, D. Bunjes and M. Schmitt

    Article first published online : 11 JAN 2008, DOI: 10.1111/j.1582-4934.2008.00234.x

  16. You have free access to this content
    Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

    American Journal of Hematology

    Volume 86, Issue 9, September 2011, Pages: 811–819, Tariq I. Mughal, Jerald P. Radich, Richard A. Van Etten, Alfonso Quintás-Cardama, Tomasz Skorski, Farhad Ravandi, Daniel J. DeAngelo, Carlo Gambacorti-Passerini, Giovanni Martinelli and Ayalew Tefferi

    Article first published online : 17 AUG 2011, DOI: 10.1002/ajh.22097

  17. Potential interactions between HIV drugs, ritonavir and efavirenz and anticancer drug, nilotinib—a study in primary cultures of human hepatocytes that is applicable to HIV patients with cancer

    The Journal of Clinical Pharmacology

    Volume 54, Issue 11, November 2014, Pages: 1272–1279, Venkateswaran C. Pillai, Robert A. Parise, Susan M. Christner, Michelle A. Rudek, Jan H. Beumer and Raman Venkataramanan

    Article first published online : 27 MAY 2014, DOI: 10.1002/jcph.333

  18. Nilotinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11, November 2008, Pages: 1374–1382, Anthony Jarkowski and Richard P. Sweeney

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.28.11.1374

  19. Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System

    American Journal of Hematology

    Jorge Cortes, Michael Mauro, Juan Luis Steegmann, Giuseppe Saglio, Rachpal Malhotra, Jon A. Ukropec and Nicola T. Wallis

    Article first published online : 30 JAN 2015, DOI: 10.1002/ajh.23938

  20. Nilotinib preclinical pharmacokinetics and practical application toward clinical projections of oral absorption and systemic availability

    Biopharmaceutics & Drug Disposition

    Volume 33, Issue 9, December 2012, Pages: 536–549, Binfeng Xia, Tycho Heimbach, Handan He and Tsu-han Lin

    Article first published online : 19 NOV 2012, DOI: 10.1002/bdd.1821